Log in to save to my catalogue

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer'...

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer'...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_910622b74ed84c4290cac0ddb3e7c3d1

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

About this item

Full title

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2024-12, Vol.16 (1), p.274-15, Article 274

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cerebrospinal fluid (CSF) biomarkers of synaptic dysfunction, neuroinflammation, and glial response, complementing Alzheimer's disease (AD) core biomarkers, have improved the pathophysiological characterization of the disease. Here, we tested the hypothesis that the co-expression of multiple CSF biomarkers will help the identification of AD-like ph...

Alternative Titles

Full title

Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_910622b74ed84c4290cac0ddb3e7c3d1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_910622b74ed84c4290cac0ddb3e7c3d1

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-024-01629-y

How to access this item